Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients

References

• Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367–2375.
   PubMed Web of Science ®Google Scholar
• Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–116.
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):16.
   PubMed Web of Science ®Google Scholar
• Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K; International Working Group on the Diabetic F. Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents. Diabetes Metab Res Rev. 2016;32(Suppl 1):7–15.
   PubMedGoogle Scholar
• Jiang Y, Huang S, Fu X, et al. Epidemiology of chronic cutaneous wounds in China. Wound Repair Regen. 2011;19(2):181–188.
   PubMed Web of Science ®Google Scholar
• Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747–755.
   PubMed Web of Science ®Google Scholar
• Middleton M, Thatcher N. G- and GM-CSF. Int J Antimicrob Agents. 1998;10(2):91–93.
   PubMed Web of Science ®Google Scholar
• Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56(6):947–958.
   PubMed Web of Science ®Google Scholar
• Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2013;2013(8):CD006810.
   Google Scholar
• Jones TC. The effects of rhGM-CSF on macrophage function. Eur J Cancer. 1993;29A(Suppl 3):S10–13.
   Google Scholar
• Bussolino F, Wang JM, Defilippi P, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature. 1989;337(6206):471–473.
   PubMed Web of Science ®Google Scholar
• Da Costa RM, Ribeiro Jesus FM, Aniceto C, Mendes M. Randomized, double-blind, placebo-controlled, dose- ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 1999;7(1):17–25.
   PubMed Web of Science ®Google Scholar
• Gabbiani G. Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis. Pathol Res Pract. 1994;190:9–10.
   Web of Science ®Google Scholar
• Rho CR, Park MY, Kang S. Effects of Granulocyte-Macrophage Colony-Stimulating (GM-CSF) Factor on Corneal Epithelial Cells in Corneal Wound Healing Model. PLoS One. 2015;10(9):e0138020.
   PubMed Web of Science ®Google Scholar
• Lim JY, Choi BH, Lee S, Jang YH, Choi JS, Kim YM. Regulation of wound healing by granulocyte-macrophage colony-stimulating factor after vocal fold injury. PLoS One. 2013;8(1):e54256.
   PubMed Web of Science ®Google Scholar
• Mann A, Breuhahn K, Schirmacher P, Blessing M. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol. 2001;117(6):1382–1390.
   PubMed Web of Science ®Google Scholar
• Fang Y, Gong SJ, Xu YH, Hambly BD, Bao S. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol. 2007;157(3):458–465.
   PubMed Web of Science ®Google Scholar
• Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol. 1999;38(5):380–386.
   PubMed Web of Science ®Google Scholar
• Jaschke E, Umlauft J, Palmer-Reichel K, Oberaigner W, Schmuth M. Low-dose topical recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) therapy for chronic venous leg ulcers, 10-year follow-up. Dermatologie. 2023;74(1):41–48.
   Google Scholar
• Fernberg JO, Brosjo O, Friesland S, Masucci G. GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy. Med Oncol. 2001;18(3):231–235.
   PubMed Web of Science ®Google Scholar
• Hu X, Sun H, Han C, Wang X, Yu W. Topically applied rhGM-CSF for the wound healing: a systematic review. Burns. 2011;37(5):729–741.
   PubMed Web of Science ®Google Scholar
• Siddiqui FH, Biundo JJ, Moore C, Ermitano ML, Ortigas AP, DeFrancesch F. Recombinant granulocyte macrophage colony stimulating factor (rhu-GM-CSF) in the treatment of extensive leg ulcers: a case report. Surgery. 2000;127(5):589–592.
   PubMed Web of Science ®Google Scholar
• Karlafti E, Savopoulos C, Hatzitolios A, Didangelos T. Local Use of Granulocyte-Macrophages Colony Stimulating Factor in Treatment of Chronic Diabetic Neuropathic Ulcer (Case Review). Georgian Med News. 2018;1(277):21–27.
   Google Scholar
• Kyaw BM, Jarbrink K, Martinengo L, Car J, Harding K, Schmidtchen A. Need for Improved Definition of “Chronic Wounds” in Clinical Studies. Acta Derm Venereol. 2018;98(1):157–158.
   PubMed Web of Science ®Google Scholar
• Wang A, Lv G, Cheng X, et al. Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition). Burns Trauma. 2020;8:tkaa017.
   PubMed Web of Science ®Google Scholar
• Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3273.
   PubMedGoogle Scholar
• Chuan F, Tang K, Jiang P, Zhou B, He X. Reliability and validity of the perfusion, extent, depth, infection and sensation (PEDIS) classification system and score in patients with diabetic foot ulcer. PLoS One. 2015;10(4):e0124739.
   PubMed Web of Science ®Google Scholar
• Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care. 2002;25(11):2010–2015.
   PubMed Web of Science ®Google Scholar
• Masson-Meyers DS, Andrade TAM, Caetano GF, et al. Experimental models and methods for cutaneous wound healing assessment. Int J Exp Pathol. 2020;101(1–2):21–35.
   PubMed Web of Science ®Google Scholar
• Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229.
   PubMed Web of Science ®Google Scholar
• Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736–1743.
   PubMed Web of Science ®Google Scholar
• Postiglione L, Montagnani S, Riccio A, et al. Expression of GM-CSF receptor and “in vitro” effects of GM-CSF on human fibroblasts. Life Sci. 1998;63(5):327–336.
   PubMed Web of Science ®Google Scholar
• Yan M, Hu Y, Yao M, Bao S, Fang Y. GM-CSF ameliorates microvascular barrier integrity via pericyte-derived Ang-1 in wound healing. Wound Repair Regen. 2017;25(6):933–943.
   PubMed Web of Science ®Google Scholar
• Bernasconi E, D’Angelo F, Michetti P, Velin D. Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities. Pathobiology. 2014;81(4):183–189.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Tamma R. Hematopoietic growth factors and tumor angiogenesis. Cancer Lett. 2019;440-441:47–53.
   PubMed Web of Science ®Google Scholar
• Khabipov A, Freund E, Liedtke KR, et al. Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells. Cancers. 2021;13(11).
   PubMed Web of Science ®Google Scholar
• Fang Y, Shen J, Yao M, Beagley KW, Hambly BD, Bao S. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. Br J Dermatol. 2010;162(3):478–486.
   PubMed Web of Science ®Google Scholar
• Canturk NZ, Vural B, Esen N, et al. Effects of granulocyte-macrophage colony-stimulating factor on incisional wound healing in an experimental diabetic rat model. Endocr Res. 1999;25(1):105–116.
   PubMed Web of Science ®Google Scholar
• Kaplan G, Walsh G, Guido LS, et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med. 1992;175(6):1717–1728.
   PubMed Web of Science ®Google Scholar
• Sawaya AP, Stone RC, Brooks SR, et al. Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. Nat Commun. 2020;11(1):4678.
   PubMed Web of Science ®Google Scholar
• Li J, Liu W, Zhang G, Wang D, Lou H, Duang J. Effectiveness of recombinant human granulocyte macrophage colony-stimulating factor for treating deep second-degree burns: a systematic review and meta-analysis. BMJ Mil Health. 2020;166(5):352–357.
   PubMedGoogle Scholar
• Guest JF, Fuller GW, Vowden P. Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes. Int Wound J. 2018;15(1):43–52.
   PubMed Web of Science ®Google Scholar
• Shao S, Pan R, Chen Y. Autologous Platelet-Rich Plasma for Diabetic Foot Ulcer. Trends Endocrinol Metab. 2020;31(12):885–890.
   PubMed Web of Science ®Google Scholar
• Sorber R, Abularrage CJ. Diabetic foot ulcers: epidemiology and the role of multidisciplinary care teams. Semin Vasc Surg. 2021;34(1):47–53.
   PubMed Web of Science ®Google Scholar
• Crocker RM, Palmer KNB, Marrero DG, Tan TW. Patient perspectives on the physical, psycho-social, and financial impacts of diabetic foot ulceration and amputation. J Diabetes Complications. 2021;35(8):107960.
   PubMed Web of Science ®Google Scholar
• Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37(3):651–658.
   PubMed Web of Science ®Google Scholar
• Kerr M, Barron E, Chadwick P, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995–1002.
   PubMed Web of Science ®Google Scholar